Company intelligence / Profile preview

Vaksindo

Bogor, West Java, Indonesiavaksindo-india.com ↗

Ownership: Private
Employees: ~3000
Development stage: Commercial

Overview

Vaksindo is a leading animal vaccine manufacturer with commercialized products for major livestock diseases. The company has demonstrated success with vaccines targeting key pathogens such as Newcastle disease virus, infectious bronchitis virus, and avian influenza. Its products are widely used across Asia and Africa, supported by GMP-certified manufacturing facilities and international collaborations.

Therapeutic areas: Infectious Diseases
Modalities: VaccineTissue culture-based vaccineEgg-based vaccineBacterial vaccine
Industry: Veterinary

Drug pipeline

3 assets

VAKSIMUNE Coryza LE

Commercial

Indications: Infectious Coryza

2 more assets in the full pipeline.

Request access →

Partnerships

Nisseikan Japan (initial collaboration partner)Collaborations with international research institutes

Beyond the preview

Go deeper on Vaksindo.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaksindo.

Explore the full profile